Amadeus and Angels Seed Fund
Archangel investors have committed £1m to the Amadeus and Angels Seed Fund, which invests in UK based technology opportunities that can revolutionise markets and that need a seed stage investment to prove out the opportunity. With £10m directly under management Amadeus seeks companies with ambitious teams, powerful ideas and a defensible technology or competitive advantage.
Seraphim Capital is a £30m venture capital Fund in which Archangel investors have committed £1m. The Fund's primary focus is on UK centric companies looking for equity capital of between £0.75 million and £2.0 million. The Fund's unique strength is its network of private investors, a national group consisting of some of the UK's most successful and influential business leaders. These are typically CEOs, Chairmen, non-exec directors and successful entrepreneurs who are re-cycling returns from their own enterprises.
Cable gets to grips with Great British design
25 Jun 2014MGB Biopharma Expands Scientific Advisory Board (SAB) with Medical Microbiologist Dr Stephanie Dancer
Business Secretary, Vince Cable, saw bionic limbs, an airship and a model of a hypersonic aircraft when he launched the ‘Pioneering Great British Products' report at Liverpool's Life Sciences University Technical College.
23 Jun 2014Touch Bionics founder receives Queen’s Honour
MGB Biopharma, a biopharmaceutical company developing truly novel anti-infectives, announces today that Dr Stephanie Dancer, an internationally renowned medical microbiologist, has joined its scientific advisory board (SAB). She will help oversee the development of MGB Biopharma’s lead antibiotic candidate, MGB-BP-3. An oral formulation of MGB-BP-3 is ready to enter Phase I development for Clostridium difficile, and an iv presentation is in late preclinical development for Gram-positive hospital acquired infections.
16 Jun 2014Touch Bionics introduces new control method for bionic hand
David Gow named Commander of the Order of the British Empire
Touch Bionics, a provider of world-leading prosthetic technologies, is proud to announce that the company's founder, David Gow, was named Commander of the Order of the British Empire (CBE) in this year's Queen's Birthday Honours list.
14 May 2014Technology Strategy Board Biomedical Catalyst Award to Drive Development of Novel System to Assess and Manage Tooth Decay (Dental Caries)
Livingston, Scotland – May 14, 2014 – Touch Bionics, a provider of world-leading prosthetic technologies, has announced the introduction of the latest enhancements to the i-limb™ ultra revolution at the OTWorld 2014 International Congress taking place in Leipzig, Germany.
09 May 2014
Calcivis, a medical devices company focused on revolutionising the management of tooth decay, today announces that it has received a prestigious Biomedical Catalyst award co-funding a £0.5m development programme and raised a further £0.8m in equity funding from existing investors Archangel Informal Investment and the Scottish Investment Bank, the investment arm of Scottish Enterprise.